Primary Care News

BOSTON — Most people in the United States do not get enough vitamin D, but supplementation helps patients reach the daily recommended dietary allowance, according to a speaker at the ACP Internal Medicine Meeting.

The FDA approved pivmecillinam tablets to treat uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus for women, according to an agency press release.

A biosimilar for golimumab has demonstrated therapeutic equivalence in rheumatoid arthritis, with no clinically meaningful safety differences, according to a press release from the manufacturer.

The FDA announced this week that testing has identified genetic traces of highly pathogenic avian influenza virus in pasteurized cow milk samples collected in the United States.

More than half of people expecting a baby said in a survey that they were “very likely” to get vaccinated against respiratory syncytial virus during pregnancy, researchers reported.

HOUSTON — Using social network analysis, researchers were able to show how health care facilities in Colorado are connected by patient transfers, which allowed them to identify potential outbreak origins.

The use of hormone therapy among women aged 65 years or older was associated with reductions in the risks for mortality, certain cancers and cardiovascular outcomes that varied by hormone therapy type, a recent study found.

As cases of botulism-like illnesses continue to rise, the CDC has issued a Health Alert Network Health Advisory to warn clinicians about risks associated with counterfeit or mishandled botulinum toxin injections.

Among patients with chronic coronary syndrome, women were less likely than men to be treated with lipid-lowering therapy, researchers reported at ESC Preventive Cardiology 2024.